Blue Horseshoe Stocks: IZEA Recap & More

Izea Worldwide, Inc. IZEA

IZEA is a stock that we have been following for several weeks. We highlighted this play back on August 12th, and would subsequently observe a low of 1.04. In two definitive pushes, the stock has gained quite a bit of ground over roughly the past six weeks.

Yesterday it managed a new high of 3.00, which marks an overall increase from its mid-August low of 188%


Snap, Inc. SNAP

We’re always scraping the barrel for a good bottom play, and we want to place SNAP on watch for just that reason this morning.

A thirteen dollar stock just two months ago as you can see on the included chart snapshot, SNAP has now fallen below the eight dollar mark, and is egregiously oversold at the present time. We’ll keep tabs on this play moving forward, as a rebound appears imminent at some point in the near future.



Comstock Mining Inc. LODE

Lastly, we want to backtrack to Monday’s report, in which we designated LODE as a stock to watch.  It certainly was something to see this week as it ran from a low of .1201 to as high as .315. That’s a 162% intraweek push.


Extended Watchlist: 
PLX, AMPE, SPI, TGC, PBR, MCIG, MYHI,

Blue Horseshoe Stocks: QSIM, USRM Updates & More

U.S. Stem Cell, Inc. USRM

We tagged USRM in our report on Monday for the first time in quite awhile, and reported back to our readers yesterday morning on the excellent 72% push it made from .014-.0241. We also mentioned the strength of its close and increased volume, noting that we’d want to continue keeping a close eye on the stock.

Yesterday’s session provided a prime example of why we doubled down on USRM for the second day in a row, with the stock streaking to an impressive new high. It traded up from it low of .0245 and smashed through the nickel barrier, reaching .0545 for a hefty intraday gain of 122%

From our observed low on Monday, the move represented an overall two-day upswing of 289%


QuantumSphere, Inc. QSIM

We noticed some heightened activity in QSIM in yesterday morning’s premarket scan, and included the stock in our extended watchlist for the day. It was a good thing that we did, because the stock put up an awesome performance, continuously ramping its way up the chart for essentially the entire session.

From its early low of .0043, QSIM was shot out of a cannon and reached a high of .011 just prior to the closing bell, for an intraday increase of 156% which came on heavy volume, on the order of seven times the 30-day average.

With such a bullish session, we’re certainly going to want to keep QSIM on tap for further potential moves, be it an immediate continuation of this bullish trend, or a dip-and-rip scenario.


Vapor Group, Inc. VPOR

Rounding off yesterday’s top movers was VPOR. Like the previously-mentioned play, we caught this one on our routine morning scan and took note of an increase in volume and price action in the prior session.

The momentum carried over nicely, with VPOR trading up from a low of .00355 and reaching .0053, for an intraday pop of 49% It marked the third straight day of higher highs and higher lows for the stock, so it too will remain on our watchlist moving forward.


Lowes Companies, Inc. LOW – Options Idea

Lowes joined the earnings bonanza this morning with an impressive set of figures in their Q4 report. We are going to be tracking a range of short-term options to possibly take advantage of the commotion.

Our targets are going to be the LOW Weekly $79-81 Calls.


Extended Watchlist:
CCTL, RSII, MYHI, HMCP, OTTV, THCT

Blue Horseshoe Stocks: News Plays & Special Reminder

Aeterna Zentaris, Inc. AEZS

AEZS is gapping up this morning on the heels of some news. It’s been quite a few months since we last mentioned this stock. That was back in the fall, and we subsequently witnessed quite a surge from the stock after that.

Since then, so far in 2017 the stock has come down to record new annual lows, and recently has been making incremental increases off of that bottom. In light of today’s news, described below, we think it’s a good time to put AEZS back on a more intensive watch.

The company announced this morning, following a comprehensive review Phase 3 clinical data on Macrilen™ for the evaluation of growth hormone deficiency, that Macrilen™ demonstrated performance supportive of achieving registration with the FDA. The FDA has agreed to consider the Company’s conclusions during a Type A meeting, which is currently being scheduled. (>>View PR)


Zosano Pharma Corp. ZSAN

Speaking of fresh news plays, we also want to highlight the announcement coming from ZSAN this morning that presently has the stock gapping up in the premarket to the tune of 50%

This morning ZSAN reported that in its ZOTRIP pivotal efficacy study, the company’s M207 transdermal migraine therapy patch met both primary, as well as secondary endpoints. It certainly explains the premarket hoopla, and warrants our observation as we kick off a new trading week.

The chart also has some attractive features which we’ve pointed out on the snapshot below:


**SPECIAL REMINDER**

To wrap things up this morning, we want to leave our readers with a quick heads up on a big Tuesday coming up. We’ve got a special report coming out tomorrow prior to the opening bell. It could represent quite an opportunity, so tomorrow is definitely not the day to miss out on our premarket report!

Be sure to stay locked onto your email inboxes or BlueHorseshoeStocks.com tomorrow between 9:00 to 9:15AM, and lean on those refresh buttons!


Extended Watchlist:
MCIG, MYHI, ADVT, MJTK, QSIM, NK